http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018317768-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c5d2eeb758322b39d6a2110f01bb4bc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6821
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B90-00
filingDate 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7df486892b19acfdf71870e523617acc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48a8d936ecddb375943616c30b8c0c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8199d0f4078b4bcbe0835e28c36ba23e
publicationDate 2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018317768-A1
titleOfInvention Implantable Micro-Fluidic Device for Monitoring of Intra-Ocular Pressure
abstract Glaucoma is the second most common cause of blindness in the global world. It is a multifactorial disease with several risk factors, of which intraocular pressure (IOP) is the most important. IOP measurements are used for glaucoma diagnosis and patient monitoring. IOP has wide diurnal fluctuation, and is dependent on body posture, so the occasional measurements done by the eye care expert in clinic can be misleading. We provide an implantable sensor, based on microfluidic principles, which in one example has 1 mmHg limit of detection, high sensitivity and excellent reproducibility. This sensor has an optical interface, which enables IOP to be read with, for example, a cell phone camera. The design, fabrication, along with the option of self-monitoring are promising steps toward better patient care and treatment for this devastating disease.
priorityDate 2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012302861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013055819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014046439-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411130

Total number of triples: 23.